265 related articles for article (PubMed ID: 25976154)
1. Serum IL-33 levels are increased in patients with psoriasis.
Mitsui A; Tada Y; Takahashi T; Shibata S; Kamata M; Miyagaki T; Fujita H; Sugaya M; Kadono T; Sato S; Asano Y
Clin Exp Dermatol; 2016 Mar; 41(2):183-9. PubMed ID: 25976154
[TBL] [Abstract][Full Text] [Related]
2. IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation.
Balato A; Lembo S; Mattii M; Schiattarella M; Marino R; De Paulis A; Balato N; Ayala F
Exp Dermatol; 2012 Nov; 21(11):892-4. PubMed ID: 23163661
[TBL] [Abstract][Full Text] [Related]
3. Correlation of IL-12, IL-22, and IL-23 in patients with psoriasis and metabolic syndrome. Preliminary report.
Brito-Luna MJ; Villanueva-Quintero DG; Sandoval-Talamantes AK; Fafutis-Morris M; Graciano-Machuca O; Sanchez-Hernandez PE; Alvarado-Navarro A
Cytokine; 2016 Sep; 85():130-6. PubMed ID: 27344023
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities in cytokine secretion from mesenchymal stem cells in psoriatic skin lesions.
Liu R; Yang Y; Yan X; Zhang K
Eur J Dermatol; 2013; 23(5):600-7. PubMed ID: 24135516
[TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis.
Shimauchi T; Hirakawa S; Suzuki T; Yasuma A; Majima Y; Tatsuno K; Yagi H; Ito T; Tokura Y
J Dermatol; 2013 Oct; 40(10):805-12. PubMed ID: 23915382
[TBL] [Abstract][Full Text] [Related]
7. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.
Wang F; Smith N; Maier L; Xia W; Hammerberg C; Chubb H; Chen C; Riblett M; Johnston A; Gudjonsson JE; Helfrich Y; Kang S; Fisher GJ; Voorhees JJ
Br J Dermatol; 2012 Jul; 167(1):92-102. PubMed ID: 22458549
[TBL] [Abstract][Full Text] [Related]
8. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis.
Wolk K; Witte E; Warszawska K; Schulze-Tanzil G; Witte K; Philipp S; Kunz S; Döcke WD; Asadullah K; Volk HD; Sterry W; Sabat R
Eur J Immunol; 2009 Dec; 39(12):3570-81. PubMed ID: 19830738
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-33 affects cytokine production by keratinocytes in vitiligo.
Li P; Ma H; Han D; Mou K
Clin Exp Dermatol; 2015 Mar; 40(2):163-70. PubMed ID: 25251808
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
[TBL] [Abstract][Full Text] [Related]
11. Elevation of serum squamous cell carcinoma antigen 2 in patients with psoriasis: associations with disease severity and response to the treatment.
Watanabe Y; Yamaguchi Y; Komitsu N; Ohta S; Azuma Y; Izuhara K; Aihara M
Br J Dermatol; 2016 Jun; 174(6):1327-36. PubMed ID: 26822223
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profiles during infliximab monotherapy in psoriatic arthritis.
Mastroianni A; Minutilli E; Mussi A; Bordignon V; Trento E; D'Agosto G; Cordiali-Fei P; Berardesca E
Br J Dermatol; 2005 Sep; 153(3):531-6. PubMed ID: 16120138
[TBL] [Abstract][Full Text] [Related]
13. Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations.
Kastelan D; Kastelan M; Massari LP; Korsic M
Med Hypotheses; 2006; 67(6):1403-5. PubMed ID: 16844318
[TBL] [Abstract][Full Text] [Related]
14. Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells.
Kanda N; Kamata M; Tada Y; Ishikawa T; Sato S; Watanabe S
J Leukoc Biol; 2011 Jun; 89(6):935-44. PubMed ID: 21367976
[TBL] [Abstract][Full Text] [Related]
15. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes.
Xuan ML; Lu CJ; Han L; Xiang Y
Chin J Integr Med; 2015 Feb; 21(2):108-14. PubMed ID: 25523599
[TBL] [Abstract][Full Text] [Related]
17. New Interleukins in Psoriasis and Psoriatic Arthritis Patients: The Possible Roles of Interleukin-33 to Interleukin-38 in Disease Activities and Bone Erosions.
Li J; Liu L; Rui W; Li X; Xuan D; Zheng S; Yu Y; Zhang J; Kong N; Zhu X; Zou H; Wan W; Xue Y
Dermatology; 2017; 233(1):37-46. PubMed ID: 28490011
[TBL] [Abstract][Full Text] [Related]
18. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.
Chiricozzi A; Guttman-Yassky E; Suárez-Fariñas M; Nograles KE; Tian S; Cardinale I; Chimenti S; Krueger JG
J Invest Dermatol; 2011 Mar; 131(3):677-87. PubMed ID: 21085185
[TBL] [Abstract][Full Text] [Related]
19. Comano's (Trentino) thermal water interferes with tumour necrosis factor-alpha expression and interleukin-8 production and secretion by cultured human psoriatic keratinocytes: yet other mechanisms of its anti-psoriatic action.
Dal Pra I; Chiarini A; Pacchiana R; Zumiani G; Zanoni M; Armato U
Int J Mol Med; 2007 Mar; 19(3):373-9. PubMed ID: 17273783
[TBL] [Abstract][Full Text] [Related]
20. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]